I’m over in Maine this week, attending the Gordon Research Conference on Parkinson’s at the Sunday River resort up in the Northern Appalachian mountains. Already a fascinating meeting, and it has only just begun.
Just out in Expert Opinion on Therapeutic Targets, Susanna Cogo, Elisa Greggio and I talk about LRRK2 as a drug target.
The manuscript is available online here:
I am working on the gold open access for this, and will post an update once it is up and available for all to read!
Just out in PLoS Medicine, a study from Alastair Noyce on the interplay between body mass index (BMI) and risk for Parkinson’s disease. This uses a genetic technique called Mendelian randomisation to test whether there is a causal link between two areas of biology. Fascinatingly Alastair’s results suggests that increased BMI is associated with a reduced risk of Parkinson’s, although what underlies this link isn’t clear and there are significant health implications of raised BMI beyond PD. A very thought provoking piece indeed.
Read all about it at: